ENTITY

Abivax (ABVX FP)

2
Analysis
Health Care • France
Abivax is a clinical-stage biotechnology company. The Company focuses on developing therapeutics that harness the body's natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. Abivax operates in France.
more
Company Event • 14 Dec 2026 16:00 • Upcoming
Add To Calendar

Q3 2026

Company Event • 22 Sep 2026 04:05 • Upcoming
Add To Calendar

Q2 2026

Company Event • 10 Jul 2026 14:00 • Upcoming
Add To Calendar

Corporate presentation

Company Event • 30 Jun 2026 04:30 • Latest

Study result

Company Event • 24 Mar 2025 10:30 • Upcoming
Add To Calendar

H2 2024

x